Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Xiaflex

 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

collagenase Clostridium histolyticum
collagenase Clostridium histolyticum 0.9 MG Injection [Xiaflex]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
Safety and effectiveness of collagenase clostridium histolyticum in the treatment of Peyronie's disease using a new modified shortened protocol
To evaluate the efficacy and safety of collagenase clostridium histolyticum (CCH; Xiapex®, Xiaflex®) in the treatment of Peyronie… Expand
Review
2014
Review
2014
Experience in the use of collagenase clostridium histolyticum in the management of Peyronie’s disease: current data and future prospects
Introduction: Peyronie’s disease (PD) is a chronic wound-healing disorder characterized by formation of fibrous inelastic… Expand
  • table 1
  • table 2
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE